STOCK TITAN

Phibro Animal Health Corporation (PAHC) Stock News, Feb-Aug 2021

PAHC NASDAQ

Phibro Animal Health Corporation reports developments in animal health, mineral nutrition and performance products for food-animal markets. The company develops, manufactures and markets antibacterials, anticoccidials, nutritional specialty products, vaccines and mineral nutrition products for poultry, swine, beef and dairy cattle, and aquaculture in the United States and international markets.

Recurring PAHC news includes quarterly results and guidance, cash dividend declarations on Class A and Class B common stock, investor conference participation and regulatory updates affecting antimicrobial products such as virginiamycin and bacitracin. Company updates also address product portfolio activity, acquisition-related effects, input and distribution costs, foreign-currency impacts and tools such as PhibroVet for veterinary prescription management.

Rhea-AI Summary

Phibro Animal Health Corporation (Nasdaq: PAHC) reported strong Q4 and full-year results for fiscal year 2021, with net sales of $220 million in Q4, up 19% year-over-year, and $833 million for the year, an increase of 4%. Net income surged to $17 million in Q4, reflecting a 203% increase, and $54 million for the year, a 62% rise. Diluted EPS also rose to $0.42 for Q4 and $1.34 for the full year. Guidance for FY 2022 projects net sales of $840-$870 million and net income of $45-$47 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.93%
Tags
-
Rhea-AI Summary

Phibro Animal Health Corporation (Nasdaq: PAHC) will participate in the Morgan Stanley Virtual Global Healthcare Conference on September 9, 2021, at 9:30 AM ET. Chairman and CEO Jack Bendheim, CFO Damian Finio, and EVP Daniel Bendheim will address analysts and investors during the session. The live audio presentation can be accessed on the company’s Investor Relations website, with a replay also available. Phibro focuses on developing a wide range of animal health and mineral nutrition products for livestock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
conferences
-
Rhea-AI Summary

Phibro Animal Health Corporation (Nasdaq:PAHC) will participate in the Bank of America Virtual Global Healthcare Conference on September 15, 2021, at 9:10 AM ET. Chief Financial Officer Damian Finio will present to financial analysts and investors, with a live audio available on the company's Investor Relations website. A replay will also be archived for future access. Phibro is a global developer and supplier of animal health and nutrition products, helping produce healthy food sustainably.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
conferences
Rhea-AI Summary

Phibro Animal Health Corporation (Nasdaq:PAHC) will announce its fourth quarter and fiscal year 2021 financial results on August 25, 2021, post-market. A conference call will occur on August 26, 2021, at 9:00 AM ET, where interested parties can join via phone or webcast. The company focuses on developing and supplying animal health and mineral nutrition products for livestock, aiming to enhance food production while conserving natural resources. Further details are available on their investor website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.70%
Tags
conferences earnings date
-
Rhea-AI Summary

The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) announced a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock. This dividend will be payable on September 22, 2021, to stockholders recorded on September 1, 2021. Phibro is a global developer, manufacturer, and supplier of animal health and mineral nutrition products aimed at enhancing food production efficiency while reducing resource use.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.75%
Tags
dividends
-
Rhea-AI Summary

Phibro Animal Health Corporation (NASDAQ:PAHC) reported Q3 FY2021 net sales of $212 million, a marginal increase of less than 1% year-over-year. Net income fell to $12 million, a decrease of 10%, with diluted EPS at $0.30, down by 9%. For the nine-month period, net sales reached $613 million, up slightly, while net income surged by 34% to $37 million. Adjusted EBITDA for Q3 declined by 7% to $28 million. The company received EU GMP approval for a new vaccine facility in Ireland and sees potential for a strong Q4. Financial guidance suggests Q4 net sales between $213-217 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.31%
Tags
none
Rhea-AI Summary

The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) has declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock. This dividend is payable on June 23, 2021, to shareholders on record as of June 2, 2021. Phibro Animal Health is a global developer and manufacturer of animal health and nutrition products aimed at promoting sustainable livestock production.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
dividends
-
Rhea-AI Summary

Phibro Animal Health Corporation (NASDAQ:PAHC) will announce its third quarter financial results on May 6, 2021, after market close. A conference call and webcast will follow on May 7, 2021, at 9:00 AM Eastern Time. Interested parties can access the call via phone or online, with a replay available two hours post-event. Phibro specializes in developing and supplying a range of animal health and mineral nutrition products aimed at supporting livestock health and sustainability. For details, visit investors.pahc.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
conferences earnings date
-
Rhea-AI Summary

Phibro Animal Health Corporation (NASDAQ:PAHC) will participate in the Bank of America Securities 2021 Virtual Healthcare Conference. The event is scheduled for Tuesday, May 11, 2021, at 4:15 PM ET. Key executives including Chairman and CEO Jack Bendheim, CFO Damian Finio, and Executive VP Daniel Bendheim will address analysts and investors. The live audio presentation will be accessible on the Phibro Investor Relations Website, with a replay available post-event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
conferences
Rhea-AI Summary

Phibro Animal Health Corporation (NASDAQ:PAHC) will participate in the Barclays Virtual Global Healthcare Conference on March 10, 2021, at 3:35 PM Eastern Time. The company's Chairman and CEO, Jack Bendheim, along with CFO Damian Finio, will address financial analysts and investors during the session. Interested parties can access the live audio presentation on the Phibro Investor Relations Website, with a replay available afterward. Phibro focuses on animal health and mineral nutrition products to support sustainable livestock practices.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.84%
Tags
conferences

FAQ

What is the current stock price of Phibro Animal Health (PAHC)?

Phibro Animal Health (PAHC) last closed at $35.02.

What is the market cap of Phibro Animal Health (PAHC)?

The market cap of Phibro Animal Health (PAHC) is approximately $1.4B.